Fuda Cancer Hospital - Malaysia

Fuda Cancer Hospital - Malaysia Fuda is committed to providing cancer patients around the world with the best medical care. There are totally 400 beds, of which 45 are VIP wards .
(8)

Located in Tianhe District (North Campus) and Haizhu District (South Campus) of Guangzhou City, Fuda Cancer Hospital is under the jurisdiction of Health supervision bureau of Guangdong Province, a bureau that mostly regulates government founded hospitals. Fuda is an affiliated hospital to Jinan University and is the Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of

Chinese Academy of Sciences. Fuda operates under the international standards, and was selected as the National Key Clinical Speciality hospital (Oncology) in 2010. Fuda has several highly efficient and professional teams: cryosurgical ablation team, micro-vascular intervention team, immunotherapy team, surgical teams for head-neck, chest and a team for hepato-biliary cancer. The Joint Commission International (JCI), one of the most widely recognized hospital evaluation system, accredited Fuda Cancer Hospital in 2013. In Fuda, we value technology, integrity and humanity. Life is what we hold dear here. Fuda has been providing patients around the world with high-tech, world-class medical services. With all the miracles and success made in the past decade, Fuda is striving to reach the ultimate goal to become a hospital that is specialized in most novel cancer treatment, equipped with advanced medical instrument and focuses on cutting-edge oncological science. In the past decade, Fuda has been using latest cancer-treating technologies to treat patients who were in early or advanced stage of cancer. Fuda's treatment has helped patients by significantly prolonging patient’s survival time and improving life quality. Fuda has developed a unique “3C+P” treatment model, which is, cryosurgical ablation (CSA), CANCER MICRO-VASCULAR INTERVENTION (CMI), COMBINED IMMUNOTHERAPY FOR CANCER (CIC), AND PERSONALIZED TREATMENTS (P). So far, Fuda has had more than 10,000 cases of cryosurgical ablation, which ranks No.1 in the world in terms of quantity as well as the types of cancer treated. Fuda has attracted cancer patients from more than 70 countries around the world, 70 percent of patients from foreign countries in South-East Asia, the Middle East, Oceanic, Europe and North America. Fuda has received various awards in China and abroad for outstanding achievements in treating cancer and been highly praised by patients around the world.

12/08/2026

[Patient’s Story] [Malaysia – Lung cancer]
>>> Thirteen Years Free from Nasopharyngeal Carcinoma Recurrence> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 616 4656
🌟 WhatsApp: +60 19 616 4656
🌍 Website: https://en.fudahospital.com/

[Patient Story] [Indonesia – Breast Cancer – Cryosurgery]12 Years Ago, Her Mother Beat Tongue Cancer Here; 12 Years Late...
12/08/2026

[Patient Story] [Indonesia – Breast Cancer – Cryosurgery]
12 Years Ago, Her Mother Beat Tongue Cancer Here; 12 Years Later, She Face Breast Cancer Head-On
Twelve years ago, Monika (pseudonym) witnessed her mother’s fight with cancer; today, she finds herself in the same battle.
In October 2025, 34-year-old Monika went for her annual health checkup. Young, vibrant, and living a harmonious life, everything seemed right on track. But her medical report struck like a bolt from the blue: a painless, 1 cm mass in her right breast. The needle biopsy confirmed invasive ductal carcinoma—Luminal B, HER2-positive subtype.
Consulting hospitals across Indonesia and Singapore, the consensus remained the same: surgical resection.
Monika resisted surgery. She refused to endure the physical and emotional trauma of losing a breast on top of the diagnosis itself. Furthermore, a total mastectomy is highly invasive, making post-operative recovery and breast reconstruction daunting challenges. She wondered if Guangzhou Fuda Cancer Hospital could offer a different path—such as cryoablation.
This wasn't a random thought. Twelve years prior, her mother was diagnosed with tongue cancer after suffering from recurrent mouth ulcers. At Fuda, her mother received local cryoablation combined with interventional chemotherapy. Once the tumor shrank, only a localized radical resection was needed, leaving her speech and swallowing functions virtually unaffected. Today, twelve years later, her mother remains healthy and cancer-free. With friends also recommending China's specialized oncology care, Fuda naturally re-emerged as her top choice.

Photo: Professor Zeng Zongyuan, Head and Neck Oncology Expert, examining Monika’s mother
"I trusted that the medical technology would be even more advanced after 12 years," she shared. After diving into literature on cryotherapy for breast cancer and conducting remote consultations, Monika booked her flight to Guangzhou.
In late April 2026, Monika was admitted to Ward 4 of Fuda Cancer Hospital. Comprehensive checkups revealed three lesions in her right breast (all categorized as BI-RADS 6), a BI-RADS 4a nodule in her left breast, and a slightly enlarged right axillary lymph node.
Given the clear diagnosis of invasive ductal carcinoma in the right breast and no evidence of distant metastasis, the medical team initially recommended surgical resection paired with a sentinel lymph node biopsy. However, Monika stood firm on her decision to avoid surgery.
Following extensive discussions, the medical team tailored a personalized comprehensive treatment plan for her:
Neoadjuvant Interventional Chemotherapy: Deliver high concentrations of medication directly to the tumor to shrink it;
Cryoablation: Precisely target and freeze the breast tumor cells, alongside a right axillary lymph node biopsy (which came back negative for cancer);
Post-operative Interventional Chemotherapy: Consolidate the therapeutic results;
Systemic Targeted Therapy: Maintain continuous support throughout the treatment course.
The entire strategy was designed like a precision operation, balancing local treatment with systemic care—steady, thorough, and methodical.

Photo: Dr. Zhang Ying, Attending Physician of Ward 4, conducting ward rounds
Even before starting chemotherapy, Monika knew hair loss was a common side effect. By her second interventional session, her hair began to fall out. Though minimal, it still weighed on her mind. Encouraged by her child, she walked into a salon and shaved off her thick, curly hair. In Indonesia, a shaved head on a woman is rare, yet looking in the mirror, she felt an unprecedented sense of liberation.

Photo: Monika smiling brightly in her hospital room
"Instead of watching my hair fall out day by day, I decided to press the reset button myself." From that moment, her mindset shifted. She stopped relying on fast food, quit burning the midnight oil, and began eating well, sleeping deeply, and slowing down to savor life. Today, her health is making steady progress.

Photo: Hospital leadership presenting Monika with the Cancer Fighting Warrior Certificate
From mother to daughter, across twelve years, they fought their battles in the very same place, driven by the same uncompromising spirit. Moving from a witness to a survivor, Monika’s clean-shaved head became her proudest badge of honor—not a symbol of loss, but a testament to her courage.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 196164656
🌟 WhatsApp: +60 196164656
🌍 Website: https://en.fudahospital.com/

【患者故事】【印尼-乳腺癌-冷冻】12年前,妈妈在这里赢了舌癌;12年后,我在这里直面乳癌对于癌症,12年前的莫妮卡(化名)是见证者,如今,她成了经历者。2025年10月,34岁的莫妮卡像往年一样,例行参加健康体检。她年轻、漂亮,生活安稳有...
12/08/2026

【患者故事】【印尼-乳腺癌-冷冻】
12年前,妈妈在这里赢了舌癌;12年后,我在这里直面乳癌
对于癌症,12年前的莫妮卡(化名)是见证者,如今,她成了经历者。
2025年10月,34岁的莫妮卡像往年一样,例行参加健康体检。她年轻、漂亮,生活安稳有序,一切都刚刚好。可那张报告单,却像一记闷雷,猝不及防地砸了下来——右乳有1cm大小的肿物,不痛不痒。穿刺结果提示:浸润性导管癌,Luminal B型,HER2阳性亚型。
她辗转印尼、新加坡的医院,均得到外科切除手术的结论。
莫妮卡不想手术。一来她不愿在身体已被疾病侵袭之后,再承受乳房缺损带来的身心双重伤害。二来全切手术创伤大,术后恢复和乳房重建都是比较棘手的问题。她想,广州复大肿瘤医院,或许能给出一条不一样的路——比如冷冻消融术。
这个想法,不是凭空而来。12年前,母亲因口腔溃疡反复发作被确诊为舌癌,在复大接受了局部冷冻消融联合介入化疗,肿瘤缩小后仅行局部根治切除,术后说话、吞咽几乎不受影响。如今12年过去,母亲依然健康地活着。加上身边朋友也向她推荐中国的肿瘤专科医疗,复大的名字,再次跳进她的选择。

△头颈肿瘤专家曾宗渊教授为莫妮卡母亲检查
“我相信12年后的技术会更成熟。”她翻遍乳腺癌冷冻治疗的文献,远程咨询医生,最终订下飞往广州的机票。
2026年4月底,莫妮卡住进复大医疗四科。完善相关检查后发现,莫妮卡右侧乳腺有三处病灶(均为BI-RADS 6类),左侧乳腺还有一枚4a类结节,右侧腋窝出现稍大淋巴结。
综合既往检查、穿刺病理结果,考虑到右乳腺浸润性导管癌诊断明确,且无明显远处组织器官转移征象,团队给出的首选方案仍是外科切除+前哨淋巴结活检。但莫妮卡仍是拒绝手术。
反复沟通后,医疗团队为她制定了个体化综合治疗方案——
先以术前新辅助化疗——动脉灌注化疗术,把高浓度药物精准输送给肿瘤,使其缩小;
再进行乳腺肿瘤冷冻消融,精准冻杀癌细胞,同时活检右侧腋窝淋巴结,结果未见癌;
术后进行动脉灌注化疗,巩固疗效。
全程配合系统靶向治疗。整套方案,像一场精密部署的战役,局部与全身交织,不求快,只求稳。

△医疗四科-主管医生张营查房
还没化疗之前,莫妮卡就了解过化疗的副作用——脱发。在第二次介入化疗时,她的头发已经开始掉落,虽不算多,却足以影响心绪。于是,她在孩子的鼓励下,走进理发店,把浓密的长卷发一气剃光。在印尼,女性光头,并不常见。可镜子里的她,却感到一种从未有过的轻松。

“与其每天看着头发一把把掉,不如我自己先按下重启键。”从那以后,她的生活也在悄悄改变。不再用快餐对付胃,不再用熬夜对付工作。她开始认真吃饭,好好睡觉,开始放慢节奏感受生活。目前,莫妮卡的病情整体向好。

△医院为其颁发抗癌勇士证书
从母亲到她,从12年前到如今,同一个地方,两代人的抗争,同一种不妥协的活法。从见证者到经历者,莫妮卡那颗光溜溜的脑袋,反倒成了她最自在、最骄傲的“标志”。那不是缺失,而是她选择的勇气。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 196164656
🌟Whatsapp: +60 196164656
🌍網站: https://hongkong.fudahospital.com

[Fuda News] [Pakistan]Fuda Invited to Attend the 2026 Pakistan-China Silk Road Mango FestivalOn July 26, the "2026 Pakis...
05/08/2026

[Fuda News] [Pakistan]
Fuda Invited to Attend the 2026 Pakistan-China Silk Road Mango Festival
On July 26, the "2026 Pakistan-China Silk Road Mango Festival," hosted by the Consulate General of Pakistan in Guangzhou, was grandly held in Guangzhou. As a National Key Clinical Specialty (Oncology) Hospital, Guangzhou Fuda Cancer Hospital—leveraging its deep cultivation and experience in international healthcare over the years—was honored to be invited. The hospital gathered alongside hundreds of guests from political, commercial, cultural, and media sectors to discuss the all-weather friendship between China and Pakistan, centered around a golden Pakistani mango.

For centuries, the Silk Road has conveyed taste and trust across mountains and rivers, enabling people to connect through their local products, shared values, and cherished traditions. Today, the China-Pakistan Economic Corridor, a flagship project of the "Belt and Road" Initiative, continues this spirit in a modern way, imbuing connectivity and trade with practical substance.

Not long ago, a member of the Pakistani Parliament received treatment at our hospital. During their stay, the hospital won the high trust of the MP and their family through superb medical skills and meticulous humanistic care. The Consulate General of Pakistan in Guangzhou presented President Niu Lizhi with a meaningful gift—a customized mango gift box commemorating the 75th anniversary of diplomatic relations between China and Pakistan. This was not just fruit, but an emotional token of close friendship and mutual assistance between the two peoples. At this Mango Festival, this friendship was renewed once again, serving as a vivid reflection of pragmatic cooperation between China and Pakistan in the field of health and medicine.

For a long time, Guangzhou Fuda Cancer Hospital has closely followed the pace of the national "Belt and Road" Initiative, adhering to an international path of development. Radiating from Southeast Asia, its scope has gradually expanded to Europe, the Americas, Australia, the Middle East, Russia, and Central Asia—a service footprint that aligns deeply with the route of the "Belt and Road". Especially in the field of minimally invasive cancer treatment, Fuda continuously delivers Chinese solutions, bringing hope to countless overseas patients and earning widespread respect from international peers. To date, the hospital has served patients from more than 130 countries and regions worldwide, practicing the noble concept of a "Community of Common Health for Mankind" through concrete actions.

Jointly building the "Belt and Road" pursues development, advocates win-win cooperation, and conveys hope. Being invited to the Mango Festival is both a great honor and a heavy responsibility of the era for Guangzhou Fuda Cancer Hospital. In the future, Guangzhou Fuda Cancer Hospital will continue to adhere to its original intent of being "patient-centered". Following the nation's strategic pace, using medical technology as the pen and human compassion as the ink, the hospital will deepen cooperation with Pakistan and all Silk Road partners in areas such as telemedicine, talent cultivation, and technical exchanges. May the seeds of health take root and sprout along the Silk Road just like mangoes, writing a new chapter of an era where health knows no borders and destinies are intertwined!

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 196164656
🌟 WhatsApp: +60 196164656
🌍 Website: https://en.fudahospital.com/

【复大新闻】【巴基斯坦】复大应邀出席2026年中巴丝绸之路芒果节7月26日,由巴基斯坦驻广州总领事馆主办的“2026年巴基斯坦—中国丝绸之路芒果节”在广州隆重举行。作为国家临床重点专科(肿瘤科)医院,广州复大肿瘤医院凭借多年来在国际医疗领域...
05/08/2026

【复大新闻】【巴基斯坦】
复大应邀出席2026年中巴丝绸之路芒果节
7月26日,由巴基斯坦驻广州总领事馆主办的“2026年巴基斯坦—中国丝绸之路芒果节”在广州隆重举行。作为国家临床重点专科(肿瘤科)医院,广州复大肿瘤医院凭借多年来在国际医疗领域的深耕积淀,荣誉受邀出席,与来自政、商、文、媒等各界的数百位嘉宾齐聚一堂,以一枚金灿灿的巴基斯坦芒果为引,共话中巴全天候友谊。

数个世纪以来,丝绸之路传递着风味与信任,跨越千山万水,让人们通过各自的物产、共享的价值和珍视的传统而相互了解。今天,作为“一带一路”倡议旗舰项目的中巴经济走廊,正以现代方式传承着这一精神,为互联互通和贸易,赋予了切实的内涵。

不久前,一位巴基斯坦国会议员到我院接受治疗。住院期间,医院以精湛的医术和细致入微的人文关怀,赢得了议员及其家属的高度信任。巴基斯坦驻广州总领事馆向牛立志院长赠送了一份意义非凡的厚礼——一份象征中巴建交75周年的定制芒果礼盒。这不仅是水果,更是两国人民亲密无间、守望相助的情感信物。此次芒果节上,这份情谊再度延续,成为中巴卫生健康领域务实合作的生动缩影。

长期以来,广州复大肿瘤医院始终紧跟国家“一带一路”倡议步伐,坚持走国际化发展之路。从东南亚为起点辐射,逐步拓展至欧美、澳洲、中东、俄罗斯及中亚等地区,医院的服务版图恰好与“一带一路”路线深度契合。尤其在肿瘤微创治疗领域,复大不断输出中国方案,为无数海外患者带去希望,也赢得了国际同行的广泛尊重。截至目前,医院已累计为来自全球超过130个国家和地区的患者提供服务,以实际行动践行“人类卫生健康共同体”的崇高理念。

共建“一带一路”追求的是发展、崇尚的是共赢、传递的是希望。此次受邀参加芒果节,对广州复大肿瘤医院而言,既是一份殊荣,更是一份沉甸甸的时代责任。未来,广州复大肿瘤医院将继续秉承“以患者为中心”的初心,紧随国家战略步伐,以医疗技术为笔,以仁爱之心为墨,深化与巴基斯坦及所有丝路伙伴在远程医疗、人才培养、技术交流等领域的合作,让健康的种子如芒果般在丝路沿线生根发芽,共同书写健康无国界、命运紧相连的时代新篇!

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 196164656
🌟Whatsapp: +60 196164656
🌍網站: https://hongkong.fudahospital.com

【患者故事】【马来西亚-肺癌-介入】夫妻同患肺癌,为何结果天差地别“Oh my God!难道所有煎熬还要再重新经历一遍吗?”这是小江——一位马来西亚华人,得知父亲确诊肺癌时,脑海中闪过的第一句话。几年前,母亲因肺癌离世,那段长达四年的治疗煎...
28/07/2026

【患者故事】【马来西亚-肺癌-介入】
夫妻同患肺癌,为何结果天差地别
“Oh my God!难道所有煎熬还要再重新经历一遍吗?”
这是小江——一位马来西亚华人,得知父亲确诊肺癌时,脑海中闪过的第一句话。几年前,母亲因肺癌离世,那段长达四年的治疗煎熬,至今仍是全家人心底无法抹去的阴影。当厄运似乎再次敲门,小江的担心可想而知。

小江家从事餐饮行业。两年前,父亲开始出现咳嗽有血丝、气短气促的症状,尤其是走路竟跟不上年纪更长的人,一爬坡便喘得厉害。意识到身体可能出了问题后,父亲前往当地医院检查。结果如晴天霹雳:右肺叶前段占位、右肺门带状密度异常,伴支气管阻塞;活检确诊为右肺鳞癌。全身PET-CT进一步显示,纵隔、右侧锁骨上下淋巴结已有转移,右股骨远端亦见可疑转移。
基因检测结果曾让人一度失望——未检测到可用靶向治疗的突变。但幸运的是,父亲的PD-L1高表达(TPS=60%),意味着能从免疫治疗中获益。
彼时,父亲的朋友建议他们到中国广州复大肿瘤医院就诊。其女儿曾被当地判定“治不了”,最终却在复大重获新生,如今已能四处旅游。但考虑到异地治疗的奔波,父亲选择在当地进行了14个疗程的免疫治疗。
“一开始治疗是有效的,后来就没效果了。”小江回忆道。2025年4月中旬,复查结果提示右肺肿瘤增大,大小约10.5cm,肿瘤包裹着肺血管,同时纵隔淋巴结肿大也加重了。当地医生告知,只能进行化疗,并且疗效未必理想。想到母亲当年治疗承受的痛苦,父亲一度心灰意冷:“如果结果还是那样,不如不治了。”
但希望,往往藏在转角处。
想起那位朋友女儿的成功经历,小江和父亲决定远赴广州,来到复大肿瘤医院。他们了解到,这里不仅有介入动脉灌注化疗——将药物直接送达肿瘤供血动脉,减少毒副作用;还有创伤小、无需开大刀的冷冻消融术。多种方案,给了他们重新选择的底气。
2025年5月,小江陪父亲首次踏入复大。入院检查显示,除肺部及纵隔病灶增大外,颅脑亦出现转移灶,导致视力模糊。面对小江父亲的病情,医院启动多学科联合诊疗(MDT)。主管医生李娜为其量身定制了综合治疗方案:
针对脑转移灶:采用伽马刀治疗;
针对肺部及纵隔病灶:施行介入动脉灌注化疗,直击病灶核心;
全身治疗:更换免疫药物,实现局部与全身治疗的“强强联合”。
几个疗程后,肺部病灶及淋巴结逐渐缩小,病灶活性显著降低;影像检查未见明显脑转移病灶,全身也未见明确转移;肿瘤标志物细胞角蛋白19片段(CYFRA21-1)——肺鳞癌的重要监测指标稳步降至正常。

“这两年来,我爸爸如常人一样生活。”小江言语间难掩激动。与母亲当年的痛苦经历相比,父亲的治疗过程可谓天差地别——没有剧烈副作用,恢复良好,生活质量得到了保障。
双亲相继罹患肺癌,也让小江高度警觉。她主动进行了相关基因检测,好在结果未见异常。她反思,或许厨房油烟是重要诱因。父母从事餐饮业数十年,母亲长期在油烟弥漫的环境中劳作。科学研究亦证实:烹饪油烟可导致DNA损伤或癌变,是非吸烟女性肺癌的重要危险因素之一。
而在这场漫长的抗争中,父亲本人也作出了积极改变——戒烟十年、调整心态、均衡饮食、保证充足睡眠,这些看似平凡的生活细节,成为支撑治疗成效的坚实基石。

谈及复大,小江充满感激:“这里的医疗设备先进,治疗速度反应极快,医护服务细致入微,专科问题都能得到及时解决。”在她看来,专业与温度并存的医疗,才是患者真正需要的“生命方舟”。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 196164656
🌟Whatsapp: +60 196164656
🌍網站: https://hongkong.fudahospital.com

[Patient Story] [Malaysia - Lung Cancer - Interventional Therapy]Both Husband and Wife Diagnosed with Lung Cancer: Why W...
28/07/2026

[Patient Story] [Malaysia - Lung Cancer - Interventional Therapy]
Both Husband and Wife Diagnosed with Lung Cancer: Why Were the Outcomes Worlds Apart?
"Oh my God! Do we have to go through all that torment all over again?"
This was the very first thought that flashed through the mind of Xiao Jiang, a Malaysian Chinese, when she learned about her father's lung cancer diagnosis. A few years ago, her mother passed away from lung cancer. The painful four-year struggle during that treatment remains an indelible shadow in the family's heart. When misfortune seemed to knock on their door again, Xiao Jiang's deep worry was understandable.

Xiao Jiang's family works in the catering industry. Two years ago, her father began experiencing symptoms like coughing with blood streaks, shortness of breath, and chest tightness. He couldn't even keep up with older people while walking and panted heavily whenever he walked uphill. Realizing something might be wrong with his body, he went to a local hospital for a check-up. The result came like a bolt from the blue: a space-occupying lesion in the anterior segment of the right lung lobe, abnormal band-like density in the right lung hilar region accompanied by bronchial obstruction; a biopsy confirmed right lung squamous cell carcinoma. A whole-body PET-CT scan further showed metastasis in the mediastinum and supra/infraclavicular lymph nodes on the right side, along with suspicious metastasis in the distal right femur.
The genetic testing results were initially disappointing—no actionable mutations for targeted therapy were detected. Fortunately, her father had high expression of PD-L1 (TPS=60%), which meant he could benefit from immunotherapy.
At that time, a friend of her father suggested seeking medical care at Guangzhou Fuda Cancer Hospital in China. The friend's daughter had once been deemed "untreatable" locally, but was ultimately given a new lease on life at Fuda and is now able to travel around. However, considering the travel hassle of seeking treatment overseas, her father chose to undergo 14 courses of immunotherapy locally.
"The treatment was effective at first, but later it stopped working," Xiao Jiang recalled. In mid-April 2025, a re-examination indicated that the tumor in the right lung had enlarged to about 10.5 cm, encasing the pulmonary vessels, while the enlargement of the mediastinal lymph nodes had also worsened. Local doctors informed them that chemotherapy was the only option left, and the efficacy might not be ideal. Remembering the pain her mother endured during treatment, her father felt thoroughly discouraged: "If the outcome is going to be the same, I'd rather not seek treatment anymore."
However, hope often waits just around the corner.
Recalling the successful experience of that friend's daughter, Xiao Jiang and her father decided to travel to Guangzhou and come to Fuda Cancer Hospital. They learned that Fuda offers not only interventional intra-arterial infusion chemotherapy—which delivers drugs directly to the tumor's blood supply arteries to minimize toxic side effects—but also cryoablation, a minimally invasive procedure that requires no major surgery. These diverse options gave them the confidence to choose anew.
In May 2025, Xiao Jiang accompanied her father to set foot in Fuda for the first time. Admission checks showed that besides the enlarged lung and mediastinal lesions, brain metastases had also developed, causing blurry vision. Facing her father's complex condition, the hospital activated a Multidisciplinary Team (MDT) consultation. Attending physician Dr. Li Na tailored a comprehensive treatment plan for him:
For brain metastases: Gamma Knife therapy was used;
For lung and mediastinal lesions: Interventional intra-arterial infusion chemotherapy was performed to target the core of the lesions directly;
Systemic therapy: The immunotherapy drug was switched to achieve a powerful synergy between local and systemic treatments.
After several courses of treatment, the lung lesions and lymph nodes gradually shrank, and lesion activity was significantly reduced; imaging scans showed no obvious brain metastasis, nor clear systemic metastasis; the tumor marker Cytokeratin 19 fragment (CYFRA21-1)—a crucial monitoring index for lung squamous cell carcinoma—steadily dropped to normal levels.

"For the past two years, my dad has been living like a normal person," Xiao Jiang said, unable to conceal her excitement. Compared to her mother's painful experience back then, her father's treatment journey was worlds apart—no severe side effects, good recovery, and guaranteed quality of life.
Having both parents suffer from lung cancer also made Xiao Jiang highly vigilant. She proactively underwent genetic testing herself, and thankfully, the results showed no abnormalities. She reflected that kitchen oil fumes might have been an important trigger. Her parents had worked in the catering industry for decades, and her mother had labored in oil-fume-filled environments for a long time. Scientific research has also confirmed that cooking oil fumes can cause DNA damage or carcinogenesis, serving as a major risk factor for lung cancer in non-smoking women.
In this long battle, her father also made positive personal changes—quitting smoking ten years ago, adjusting his mindset, eating a balanced diet, and ensuring adequate sleep. These seemingly ordinary lifestyle details became solid pillars supporting his treatment's success.

Speaking of Fuda, Xiao Jiang was filled with gratitude: "The medical equipment here is advanced, the treatment response is lightning-fast, and the medical care is meticulous. Any specialized issues can be resolved promptly." In her eyes, medical care that combines professionalism with warmth is the true "ark of life" patients need.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 196164656
🌟 WhatsApp: +60 196164656
🌍 Website: https://en.fudahospital.com/

21/07/2026

[Patient’s Story] [America – Thymoma – Interventional Chemo]
>>>Thymoma Relapse: Second Chance for Better Hope> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 196164656
🌟 WhatsApp: +60 196164656
🌍 Website: https://en.fudahospital.com/

Address

Level 27-05, Tower B, Pavilion Embassy, 200 Jalan Ampang
Kuala Lumpur
50450

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - Malaysia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Fuda Cancer Hospital - Malaysia:

Share

Category